Effect of immunosuppressive regimens on metabolic dysfunction-associated fatty liver disease following liver transplantation

Metabolic dysfunction-associated fatty liver disease has been linked to negative outcomes in patients with end-stage liver disease following liver transplantation. However, the influence of immunosuppressive regimens on it has not been explored.